Literature DB >> 30998341

Nanoscale Metal-Organic Framework Hierarchically Combines High-Z Components for Multifarious Radio-Enhancement.

Guangxu Lan, Kaiyuan Ni, Samuel S Veroneau, Taokun Luo, Eric You, Wenbin Lin.   

Abstract

With tunability and porosity, nanoscale metal-organic frameworks (nMOFs) can incorporate multiple components to realize complex functions for biomedical applications. Here we report the synthesis of W18@Hf12-DBB-Ir, a new nMOF assembly hierarchically incorporating three high-Z components-Hf-based metal-oxo clusters, Ir-based bridging ligands, and W-based polyoxometalates (POMs)-as a multifarious radioenhancer. Cationic Hf12-DBB-Ir was built from Hf12 secondary building units (SBUs) and [Ir(bpy)2(ppy)]+ (bpy = 2,2'-bipyridine, ppy = 2-phenylpyridine) derived dicarboxylate ligands (DBB-Ir) and then loaded with Wells-Dawson-type [P2W18O62]6- (W18) POMs to afford W18@Hf12-DBB-Ir. Upon X-ray irradiation, W18@Hf12-DBB-Ir significantly enhances hydroxyl radical generation from Hf12 SBUs, singlet oxygen generation from DBB-Ir ligands, and superoxide generation from W18 POMs, respectively. Through synergistic cell killing by these distinct reactive oxygen species, W18@Hf12-DBB-Ir elicited superb anticancer efficacy with >98% tumor regression at a low X-ray dose of 5 × 1 Gy.

Entities:  

Year:  2019        PMID: 30998341     DOI: 10.1021/jacs.9b03029

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  11 in total

1.  Nanoscale Metal-Organic Layer Isolates Phthalocyanines for Efficient Mitochondria-Targeted Photodynamic Therapy.

Authors:  Geoffrey T Nash; Taokun Luo; Guangxu Lan; Kaiyuan Ni; Michael Kaufmann; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2021-02-02       Impact factor: 15.419

2.  Multifunctional Hf/Mn-TCPP Metal-Organic Framework Nanoparticles for Triple-Modality Imaging-Guided PTT/RT Synergistic Cancer Therapy.

Authors:  Jianfeng Bao; Xiangyang Zu; Xiao Wang; Jinghua Li; Dandan Fan; Yupeng Shi; Qingchun Xia; Jingliang Cheng
Journal:  Int J Nanomedicine       Date:  2020-10-08

Review 3.  High-Z Metal-Organic Frameworks for X-ray Radiation-Based Cancer Theranostics.

Authors:  Megan J Neufeld; Alec Lutzke; Guillem Pratx; Conroy Sun
Journal:  Chemistry       Date:  2020-12-15       Impact factor: 5.236

Review 4.  Nanoscale Metal-Organic Frameworks Generate Reactive Oxygen Species for Cancer Therapy.

Authors:  Kaiyuan Ni; Guangxu Lan; Wenbin Lin
Journal:  ACS Cent Sci       Date:  2020-05-15       Impact factor: 14.553

5.  Metal-Organic Frameworks (MOFs) for Cancer Therapy.

Authors:  Mohammad Reza Saeb; Navid Rabiee; Masoud Mozafari; Francis Verpoort; Leonid G Voskressensky; Rafael Luque
Journal:  Materials (Basel)       Date:  2021-11-28       Impact factor: 3.623

Review 6.  Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years.

Authors:  Xinyan Hao; Junyong Wu; DaXiong Xiang; Yongyu Yang
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

Review 7.  Two-dimensional metal-organic frameworks: from synthesis to bioapplications.

Authors:  Weiqi Wang; Yuting Yu; Yilan Jin; Xiao Liu; Min Shang; Xiaohua Zheng; Tingting Liu; Zhigang Xie
Journal:  J Nanobiotechnology       Date:  2022-05-02       Impact factor: 9.429

8.  Ultrasmall BiOI Quantum Dots with Efficient Renal Clearance for Enhanced Radiotherapy of Cancer.

Authors:  Xin Wang; Zhao Guo; Chenyang Zhang; Shuang Zhu; Lele Li; Zhanjun Gu; Yuliang Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-01-16       Impact factor: 16.806

Review 9.  Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.

Authors:  Wenjie Sun; Shuying Li; Guiliang Tang; Yuan Luo; Shijing Ma; Shaoxing Sun; Jiangbo Ren; Yan Gong; Conghua Xie
Journal:  Int J Nanomedicine       Date:  2019-12-31

10.  Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination.

Authors:  Kaiyuan Ni; Guangxu Lan; Nining Guo; August Culbert; Taokun Luo; Tong Wu; Ralph R Weichselbaum; Wenbin Lin
Journal:  Sci Adv       Date:  2020-10-02       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.